Nacif et al v. Athira Pharma Inc et al
Case Number:
2:21-cv-00861
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Badgley Mullins
- Bernstein Litowitz
- Block & Leviton
- Breskin Johnson
- Byrnes Keller
- DLA Piper
- Glancy Prongay
- Keller Rohrback
- Labaton Keller
- Longman Law PC
- Perkins Coie
- Tousley Brain
- Wilson Sonsini
Companies
- Athira Pharma
- Jefferies Financial Group Inc.
- JMP Group Inc.
- Stifel Financial Corp.
- The Goldman Sachs Group Inc.
Sectors & Industries:
-
November 04, 2024
Errors Lower Fee Award For Athira Pharma Investors' Counsel
A Seattle federal judge has awarded $2 million in attorney fees to four firms that represented a class of Athira Pharma investors following a $10 million settlement over allegations the company's former CEO manipulated Alzheimer's drug studies, trimming the 25% fee award the firms sought due to an "overall lack of success in this litigation."
-
February 16, 2024
Athira Pharma Investors Win OK Of $10M Deal On Second Try
Over 30,000 Athira Pharma investors have scored preliminary approval of a $10 million settlement over claims its former CEO manipulated studies relating to an Alzheimer's drug, five months after a Washington federal judge rejected their first bid but let them try again to address concerns over conflicts and equitable treatment.